BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 29968906)

  • 1. Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity.
    Hong D; Fritz AJ; Zaidi SK; van Wijnen AJ; Nickerson JA; Imbalzano AN; Lian JB; Stein JL; Stein GS
    J Cell Physiol; 2018 Dec; 233(12):9136-9144. PubMed ID: 29968906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNAs in the regulation of breast cancer stem cells.
    Liu S; Clouthier SG; Wicha MS
    J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
    Liu X; Fan D
    Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation.
    Fantozzi A; Gruber DC; Pisarsky L; Heck C; Kunita A; Yilmaz M; Meyer-Schaller N; Cornille K; Hopfer U; Bentires-Alj M; Christofori G
    Cancer Res; 2014 Mar; 74(5):1566-75. PubMed ID: 24413534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMT in breast cancer stem cell generation.
    Ansieau S
    Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
    Glackin CA
    Enzymes; 2018; 44():83-101. PubMed ID: 30360816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.
    Hao J; Zhang Y; Deng M; Ye R; Zhao S; Wang Y; Li J; Zhao Z
    Int J Cancer; 2014 Sep; 135(5):1019-27. PubMed ID: 24500893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.
    Neelakantan D; Drasin DJ; Ford HL
    Cell Adh Migr; 2015; 9(4):265-76. PubMed ID: 25482627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets.
    Sato R; Semba T; Saya H; Arima Y
    Stem Cells; 2016 Aug; 34(8):1997-2007. PubMed ID: 27251010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.
    Mallini P; Lennard T; Kirby J; Meeson A
    Cancer Treat Rev; 2014 Apr; 40(3):341-8. PubMed ID: 24090504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pomegranate Extract Alters Breast Cancer Stem Cell Properties in Association with Inhibition of Epithelial-to-Mesenchymal Transition.
    Nallanthighal S; Elmaliki KM; Reliene R
    Nutr Cancer; 2017 Oct; 69(7):1088-1098. PubMed ID: 28976208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition.
    Bosukonda A; Carlson WD
    Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of p38γ MAPK in regulation of EMT and cancer stem cells.
    Xu M; Wang S; Wang Y; Wu H; Frank JA; Zhang Z; Luo J
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3605-3617. PubMed ID: 30251680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance.
    Pinto CA; Widodo E; Waltham M; Thompson EW
    Cancer Lett; 2013 Nov; 341(1):56-62. PubMed ID: 23830804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.
    Fu H; Fu L; Xie C; Zuo WS; Liu YS; Zheng MZ; Yu JM
    Oncol Rep; 2017 Feb; 37(2):1093-1099. PubMed ID: 28075453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landscape perspectives of tumor, EMT, and development.
    Yu C; Liu Q; Chen C; Yu J; Wang J
    Phys Biol; 2019 Jul; 16(5):051003. PubMed ID: 31067516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition.
    Banno A; Garcia DA; van Baarsel ED; Metz PJ; Fisch K; Widjaja CE; Kim SH; Lopez J; Chang AN; Geurink PP; Florea BI; Overkleeft HS; Ovaa H; Bui JD; Yang J; Chang JT
    Oncotarget; 2016 Apr; 7(16):21527-41. PubMed ID: 26930717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer.
    Sun L; Burnett J; Gasparyan M; Xu F; Jiang H; Lin CC; Myers I; Korkaya H; Liu Y; Connarn J; He H; Zhang N; Wicha MS; Sun D
    Oncotarget; 2016 Aug; 7(32):51408-51422. PubMed ID: 27285982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevance.
    Guo W
    Stem Cells Transl Med; 2014 Aug; 3(8):942-8. PubMed ID: 24904174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
    Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
    Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.